The National Academies Press

Currently Skimming:

Executive Summary
Pages 1-15

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.

From page 1... ... Since then the financing of care has changed dramatically, and demands for accountability and efficiency are increasingly stressing the ability of these programs to survive. Within this context, this Institute of Medicine committee was charged with examining the community-based drug abuse treatment system with the goal of facilitating new strategies for partnership and increasing synergy among those working in a variety of settings to reduce the individual and societal costs of drug addiction (see Box 1~. Read the entire page →
From page 2... ... Committee members believe a bidirectional flow of information among treatment providers, researchers, and policymakers will enhance the quality of treatment-based research, increase treatment effectiveness, inform policy, and help CBOs to thrive in an increasingly challenging and complex environment (see Figure 11. The audience for this report is quite broad and includes federal, state, and local policymakers, drug treatment researchers, community-based treatment providers (including their professional organizations) Read the entire page →
From page 3... ... Likewise, the committee was cautious not to exclude, a priori, any significant programs of interest by a determination that they were not "community-based." Thus, the public workshops included representatives from a diverse group, ranging from small local programs that would be considered community-based by the most restrictive definition, to large and complex programs sponsored by entities such as the Department of Veterans Affairs, academic medical centers, state court systems, and managed care organizations. The committee obtained information from a rich variety of sources. Read the entire page →
From page 4... ... Research participation becomes a possibility for treatment providers when community-based organizations are compensated for the costs of research participation and when program staff and investigators collaborate in construction of hypotheses, research design, and data collection, analysis, and interpretation. The level of participation in research collaborations depends on the stage of organizational development of the treatment program, compatibil Read the entire page →
From page 5... ... CCOP facilitates research collaborations and enhances the ability of treatment programs to apply research findings to the general patient population. Development of a similar mechanism for use in community-based drug and alcohol abuse treatment could catalyze research/practice collaborations and stimulate improvements in practice. Read the entire page →
From page 6... ... remaining sensitive to any potential their work has to harm consumers or treatment programs; � guarding against the misuse of their research findings and the findings of other researchers in the development of funding and regulatory policies and the design of clinical protocols; � supporting, through their work and their policy participation, consumer education on state-of-the-art clinical services; and recognizing the value of consumer participation by providing information accessible to consumers about the benefits of research, by including consumers on study advisory groups and by integrating informed consumer opinion in research proposals and study designs. Read the entire page →
From page 7... ... . Strategies for Linking Research Findings, Policy Development, and Treatment Implementation State and federal policies sometimes hinder the diffusion of knowledge flowing from research that is relevant to drug abuse treatment. Read the entire page →
From page 8... ... These data systems should not be a oneway conduit to a state database but should also provide information to the treatment programs in a usable format and become the basis of public reports on outcomes. Encouraging state substance abuse authorities to expand researcher, provider, and consumer participation in the development of licensing standards, staff development requirements, and initiatives to enhance consumer participation. Read the entire page →
From page 9... ... Strategies for Dissemination and Knowledge Transfer The committee found at least four factors that inhibit diffusion of drug abuse treatment knowledge: (1) the structure of treatment delivery systems; (2) Read the entire page →
From page 10... ... NIDA-, NIAAA-, and AHCPR-sponsored research on drug treatment knowledge dissemination would help to reduce barriers to the transfer of treatment knowledge and encourage treatment programs and policymakers to adopt proven treatments. Research findings need to be prepared in a form and disseminated within channels that enhance availability and acceptability to community-based treatment programs especially front-line treatment staff. Read the entire page →
From page 11... ... RECOMMENDATION 9. CSAT and NIDA, in collaboration with state substance abuse authorities, should develop public awareness programs to encourage consumers and their families to recognize high quality treatment programs so they will begin to demand that treatment programs include research-proven treatment approaches within their treatment models. Read the entire page →
From page 12... ... RECOMMENDATION 11. University training programs in the health professions should: � enhance exposure of students to didactic teaching about substance abuse and dependence; � require didactic teaching as well as supervised clinical experiences in community-based treatment settings; � teach students to interpret substance abuse treatment research and apply research findings in their clinical practices; � work with professional organizations to enhance continuing education about the addictions within the residency training curriculum of the various health professions; and � support researchers seeking to enhance collaborative relation Read the entire page →
From page 13... ... . Support training for consumers and their families to become effective advocates and to develop advocacy organizations to promote state-ofthe-art treatment and treatment research, as well as consumer participation in policy areas such as the development of standards of care. Read the entire page →
From page 14... ... . participation Develop research infrastructure and network of communitybased drug treatment organizations (CBOs) Read the entire page →
From page 15... ... Support pre/post NIDA, other community-based doctoral training for NIH training research collaboration community-based programs research collaboration 11. Provide teaching, supervised clinical experience and CME in addiction treatment for all health professions University training programs 12. Read the entire page →

From page 1...

... Since then the financing of care has changed dramatically, and demands for accountability and efficiency are increasingly stressing the ability of these programs to survive. Within this context, this Institute of Medicine committee was charged with examining the community-based drug abuse treatment system with the goal of facilitating new strategies for partnership and increasing synergy among those working in a variety of settings to reduce the individual and societal costs of drug addiction (see Box 1~.

Executive Summary Pages 1-15

Executive Summary
Pages 1-15